{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antidepressants",
      "depressive disorders",
      "diagnosis",
      "nosology",
      "placebo"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "29693539",
  "DateCompleted": {
    "Year": "2019",
    "Month": "03",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "03",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1192/bjp.2018.56"
    ],
    "Journal": {
      "ISSN": "1472-1465",
      "JournalIssue": {
        "Volume": "212",
        "Issue": "5",
        "PubDate": {
          "Year": "2018",
          "Month": "May"
        }
      },
      "Title": "The British journal of psychiatry : the journal of mental science",
      "ISOAbbreviation": "Br J Psychiatry"
    },
    "ArticleTitle": "We all know what we mean by treatment-resistant depression - don't we?",
    "Pagination": {
      "StartPage": "259",
      "EndPage": "261",
      "MedlinePgn": "259-261"
    },
    "Abstract": {
      "AbstractText": [
        "Although in common use, treatment-resistant depression is unhelpful both conceptually and practically. In this issue a new term, multiple-therapy-resistant major depressive disorder, is proposed; although it may be useful in guiding treatment options for patients with persisting depression, it should not be an automatic trigger for further, more invasive treatments.Declaration of interestsI.M.A. has been a consultant for pharmaceutical companies developing and marketing antidepressants and has been an author on publications that have used the term treatment-resistant depression."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuroscience and Psychiatry Unit,Division of Neuroscience and Experimental Psychology,University of Manchester and Manchester Academic Health Science Centre,Manchester M13 9PT,UK."
          }
        ],
        "LastName": "Anderson",
        "ForeName": "Ian M",
        "Initials": "IM"
      }
    ],
    "PublicationTypeList": [
      "Editorial",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Psychiatry",
    "NlmUniqueID": "0342367",
    "ISSNLinking": "0007-1250"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Br J Psychiatry. 2018 May;212(5):274-278",
      "PMID": "30517072"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depressive Disorder, Treatment-Resistant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    }
  ]
}